4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001193125-25-314156
Chief Regulatory Officer sold 10,000 shares at $45.31 ($453,053)
- Chief Regulatory Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Turner William D. · Chief Regulatory Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $15.53 | $155,300 | 32,500 | D |
| 2025-12-08 | Sale : show line 2 in the form 10b5-1 | −10,000 | $45.31 | $453,053 | 22,500 | D |
| Open-market sales · 10,000 sh · avg $45.31 · $453,053 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −10,000 | 255,000 | D |
Loading xslF345X05/ownership.xml…